GlaxoSmithKline PLC (GSK.N) Analysts | Reuters.com
Edition:
United States

GlaxoSmithKline PLC (GSK.N)

GSK.N on New York Stock Exchange

40.80USD
24 Jun 2016
Change (% chg)

$-1.76 (-4.14%)
Prev Close
$42.56
Open
$40.63
Day's High
$41.76
Day's Low
$40.61
Volume
1,922,822
Avg. Vol
761,061
52-wk High
$44.81
52-wk Low
$36.72

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.59 December 25 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 4 9,115.25 9,272.37 8,932.68 9,301.31
Quarter Ending Sep-16 4 9,758.03 9,850.99 9,616.49 9,666.83
Year Ending Dec-16 5 37,530.10 38,203.10 37,012.00 38,347.10
Year Ending Dec-17 5 38,519.10 38,906.70 38,106.10 38,553.00
Earnings (per share)
Quarter Ending Jun-16 2 0.59 0.60 0.58 --
Quarter Ending Sep-16 3 0.63 0.75 0.41 --
Year Ending Dec-16 6 2.31 2.61 1.28 2.69
Year Ending Dec-17 5 2.61 2.76 2.48 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 8,564.62 8,716.40 151.78 1.77
Quarter Ending Dec-15 8,920.50 9,617.58 697.08 7.81
Quarter Ending Sep-15 9,344.43 9,374.31 29.88 0.32
Quarter Ending Jun-15 9,141.39 9,067.52 73.87 0.81
Quarter Ending Mar-15 8,470.21 8,545.44 75.23 0.89
Earnings (per share)
Quarter Ending Mar-16 0.52 0.55 0.03 5.77
Quarter Ending Dec-15 0.49 0.55 0.06 12.24
Quarter Ending Sep-15 0.58 0.70 0.12 20.69
Quarter Ending Sep-14 0.40 0.93 0.53 129.97
Quarter Ending Dec-13 0.96 0.97 0.01 1.04

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 9,115.25 9,115.25 9,185.17 8,911.29 9,301.31
Quarter Ending Sep-16 9,758.03 9,758.03 9,833.82 9,475.30 9,666.83
Year Ending Dec-16 37,530.10 37,530.10 37,760.80 36,245.50 38,347.10
Year Ending Dec-17 38,519.10 38,519.10 38,758.60 37,514.00 38,553.00
Earnings (per share)
Quarter Ending Jun-16 0.59 0.59 0.60 -- --
Quarter Ending Sep-16 0.63 0.63 0.64 -- --
Year Ending Dec-16 2.31 2.31 2.32 2.49 2.69
Year Ending Dec-17 2.61 2.61 2.63 2.32 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 0 1
Quarter Ending Sep-16 0 0 0 1
Year Ending Dec-16 0 0 0 1
Year Ending Dec-17 0 0 0 1
Earnings
Quarter Ending Jun-16 0 0 0 1
Quarter Ending Sep-16 0 0 0 1
Year Ending Dec-16 0 0 0 1
Year Ending Dec-17 0 0 0 1

Analyst Research Reports

Report Title Price
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.